{"id":1398,"date":"2020-10-07T09:27:05","date_gmt":"2020-10-07T16:27:05","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=1398"},"modified":"2020-10-08T09:27:53","modified_gmt":"2020-10-08T16:27:53","slug":"lilly-provides-comprehensive-update-on-progress-of-sars-cov-2-neutralizing-antibody-programs","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/07\/lilly-provides-comprehensive-update-on-progress-of-sars-cov-2-neutralizing-antibody-programs\/","title":{"rendered":"Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs"},"content":{"rendered":"<ul>\n<li>[Press release, not peer-reviewed] A combination of two monoclonal antibodies showed evidence of efficacy for treatment of mild-to-moderate COVID-19. A randomized, double-blind, placebo-controlled Phase 2 trial (BLAZE-1 trial) showed that combination therapy with two of\u00a0Lilly&#8217;s SARS-CoV-2 neutralizing antibodies (LY-CoV555 and LY-CoV016) administered to patients with mild-to-moderate COVID-19 (112 received antibody, 156 received placebo) reduced viral load, symptoms, and COVID-related hospitalization and emergency room visits. The combination therapy has been generally well tolerated with no drug-related serious adverse events.<\/li>\n<\/ul>\n<p>Lilly. (Oct 7, 2020). Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs. <a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lilly-provides-comprehensive-update-progress-sars-cov-2\">https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lilly-provides-comprehensive-update-progress-sars-cov-2<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Press release, not peer-reviewed] A combination of two monoclonal antibodies showed evidence of efficacy for treatment of mild-to-moderate COVID-19. A randomized, double-blind, placebo-controlled Phase 2 trial (BLAZE-1 trial) showed that combination therapy with two of\u00a0Lilly&#8217;s SARS-CoV-2 neutralizing antibodies (LY-CoV555 and LY-CoV016) administered to patients with mild-to-moderate COVID-19 (112 received antibody, 156 received placebo) reduced viral&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/07\/lilly-provides-comprehensive-update-on-progress-of-sars-cov-2-neutralizing-antibody-programs\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-1398","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=1398"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1398\/revisions"}],"predecessor-version":[{"id":1399,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1398\/revisions\/1399"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=1398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=1398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=1398"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=1398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}